Bio-Techne, Kantaro launch COVID-19 serology test

By The Science Advisory Board staff writers

Bio-Techne and Kantaro Biosciences have launched COVID-SeroIndex, a quantitative SARS-CoV-2 immunoglobulin G (IgG) antibody research-use only kit.

The companies will jointly commercialize and distribute the assay to support the SARS-CoV-2 vaccine development community. They anticipate the kits will be available in early August.

The enzyme-linked immunosorbent assay (ELISA) will measure the presence or absence of anti-COVID-19 antibodies and titer levels of antibodies. It will use two virus antigens: a full-length spike protein and a receptor-binding domain.

Kantaro Biosciences is the commercial arm of Mount Sinai Health System.

Copyright © 2020

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking